ICD 2025: New data demonstrate Nemluvio ®'s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years

11 hours ago 1

1. Homepage
2. Finance
3. ICD 2025: New data demonstrate Nemluvio ®'s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years